These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

506 related articles for article (PubMed ID: 22932720)

  • 21. Predictive and diagnostic utility of brief neuropsychological assessment in detecting Alzheimer's pathology and progression to dementia.
    Eliassen IV; Fladby T; Kirsebom BE; Waterloo K; Eckerström M; Wallin A; Bråthen G; Aarsland D; Hessen E
    Neuropsychology; 2020 Nov; 34(8):851-861. PubMed ID: 33197198
    [No Abstract]   [Full Text] [Related]  

  • 22. Estimating Alzheimer's Disease Progression Rates from Normal Cognition Through Mild Cognitive Impairment and Stages of Dementia.
    Davis M; O Connell T; Johnson S; Cline S; Merikle E; Martenyi F; Simpson K
    Curr Alzheimer Res; 2018; 15(8):777-788. PubMed ID: 29357799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modelling prognostic trajectories of cognitive decline due to Alzheimer's disease.
    Giorgio J; Landau SM; Jagust WJ; Tino P; Kourtzi Z;
    Neuroimage Clin; 2020; 26():102199. PubMed ID: 32106025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anosognosia Is an Independent Predictor of Conversion From Mild Cognitive Impairment to Alzheimer's Disease and Is Associated With Reduced Brain Metabolism.
    Gerretsen P; Chung JK; Shah P; Plitman E; Iwata Y; Caravaggio F; Nakajima S; Pollock BG; Graff-Guerrero A;
    J Clin Psychiatry; 2017; 78(9):e1187-e1196. PubMed ID: 29022655
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease.
    Sala I; Illán-Gala I; Alcolea D; Sánchez-Saudinós MB; Salgado SA; Morenas-Rodríguez E; Subirana A; Videla L; Clarimón J; Carmona-Iragui M; Ribosa-Nogué R; Blesa R; Fortea J; Lleó A
    J Alzheimers Dis; 2017; 58(3):909-918. PubMed ID: 28527215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brainstem Volumetric Integrity in Preclinical and Prodromal Alzheimer's Disease.
    Dutt S; Li Y; Mather M; Nation DA;
    J Alzheimers Dis; 2020; 77(4):1579-1594. PubMed ID: 32925030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A 'Comprehensive Visual Rating Scale' for predicting progression to dementia in patients with mild cognitive impairment.
    Jang JW; Park JH; Kim S; Park YH; Pyun JM; Lim JS; Kim Y; Youn YC; Kim S;
    PLoS One; 2018; 13(8):e0201852. PubMed ID: 30125290
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disease state fingerprint in frontotemporal degeneration with reference to Alzheimer's disease and mild cognitive impairment.
    Muñoz-Ruiz MÁ; Hartikainen P; Hall A; Mattila J; Koikkalainen J; Herukka SK; Julkunen V; Vanninen R; Liu Y; Lötjönen J; Soininen H
    J Alzheimers Dis; 2013; 35(4):727-39. PubMed ID: 23455991
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer's disease.
    Zhang H; Therriault J; Kang MS; Ng KP; Pascoal TA; Rosa-Neto P; Gauthier S;
    Alzheimers Res Ther; 2018 Aug; 10(1):80. PubMed ID: 30115118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Research diagnostic criteria for Alzheimer's disease: findings from the LipiDiDiet randomized controlled trial.
    Rosenberg A; Solomon A; Soininen H; Visser PJ; Blennow K; Hartmann T; Kivipelto M;
    Alzheimers Res Ther; 2021 Mar; 13(1):64. PubMed ID: 33766132
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of brain amyloidosis with the incidence and frequency of neuropsychiatric symptoms in ADNI: a multisite observational cohort study.
    Goukasian N; Hwang KS; Romero T; Grotts J; Do TM; Groh JR; Bateman DR; Apostolova LG
    BMJ Open; 2019 Dec; 9(12):e031947. PubMed ID: 31857304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuropsychological criteria for mild cognitive impairment improves diagnostic precision, biomarker associations, and progression rates.
    Bondi MW; Edmonds EC; Jak AJ; Clark LR; Delano-Wood L; McDonald CR; Nation DA; Libon DJ; Au R; Galasko D; Salmon DP
    J Alzheimers Dis; 2014; 42(1):275-89. PubMed ID: 24844687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predicting progression from mild cognitive impairment to Alzheimer's disease on an individual subject basis by applying the CARE index across different independent cohorts.
    Chen J; Chen G; Shu H; Chen G; Ward BD; Wang Z; Liu D; Antuono PG; Li SJ; Zhang Z;
    Aging (Albany NY); 2019 Apr; 11(8):2185-2201. PubMed ID: 31078129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Erlangen Score Predicts Cognitive and Neuroimaging Progression in Mild Cognitive Impairment Stage of Alzheimer's Disease.
    Skillbäck T; Kornhuber J; Blennow K; Zetterberg H; Lewczuk P;
    J Alzheimers Dis; 2019; 69(2):551-559. PubMed ID: 31104027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of the National Institute on Aging-Alzheimer's Association AD criteria to ADNI.
    Lowe VJ; Peller PJ; Weigand SD; Montoya Quintero C; Tosakulwong N; Vemuri P; Senjem ML; Jordan L; Jack CR; Knopman D; Petersen RC
    Neurology; 2013 Jun; 80(23):2130-7. PubMed ID: 23645596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studying ventricular abnormalities in mild cognitive impairment with hyperbolic Ricci flow and tensor-based morphometry.
    Shi J; Stonnington CM; Thompson PM; Chen K; Gutman B; Reschke C; Baxter LC; Reiman EM; Caselli RJ; Wang Y;
    Neuroimage; 2015 Jan; 104():1-20. PubMed ID: 25285374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. White matter disease independently predicts progression from mild cognitive impairment to Alzheimer's disease in a clinic cohort.
    Prasad K; Wiryasaputra L; Ng A; Kandiah N
    Dement Geriatr Cogn Disord; 2011; 31(6):431-4. PubMed ID: 21757908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Usefulness of biomarkers in the diagnosis and prognosis of early-onset cognitive impairment.
    Balasa M; Sánchez-Valle R; Antonell A; Bosch B; Olives J; Rami L; Castellví M; Molinuevo JL; Lladó A
    J Alzheimers Dis; 2014; 40(4):919-27. PubMed ID: 24577466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Forgetting Rates on the Recency Portion of a Word List Predict Conversion from Mild Cognitive Impairment to Alzheimer's Disease.
    Turchetta CS; De Simone MS; Perri R; Fadda L; Caruso G; De Tollis M; Caltagirone C; Carlesimo GA
    J Alzheimers Dis; 2020; 73(4):1295-1304. PubMed ID: 31903988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amyloid-β Deposition and Long-Term Progression in Mild Cognitive Impairment due to Alzheimer's Disease Defined with Amyloid PET Imaging.
    Hatashita S; Wakebe D
    J Alzheimers Dis; 2017; 57(3):765-773. PubMed ID: 28304292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.